Medtronic hypertension device improves in new study, but doesn’t outdo drugs


Medtronic’s Symplicity system, which stimulates nerves near the kidneys to treat hypertension, yielded disappointing results in 2014. It did better the second time — though it failed to prove itself significantly better than drugs.

Previous On the Agenda: Annexation cases involving hundreds of acres to appear before Fort Worth City Council
Next MGH scientists get $30M to make drugs using natural psychoactives